IN8Bio

1 follower

‌

IN8bio, Inc. (“IN8bio”) is a clinical-stage biotechnology company focused on developing novel therapies for the treatment of cancers by employing allogeneic, autologous and genetically modified gamma-delta T cells.

Industries

Biotechnology, Health Care

Headquarters

Birmingham, United States

Employees

11-50

Links

Org chart

William Ho

Director, President, CEO & Co-Founder

William Ho

Collapse

Kate Rochlin

COO

Pat McCall

CFO

Lawrence Lamb

EVP, Chief Scientific Officer & Co-Founder

Stacey Bilinski

Vice President Clinical Operations

Stacey Bilinski

VP, Clinical Operations

Patrick McCall

Chief Financial Officer

Teams

Leadership Team

4 members

Medical and Technical Roles

4 members

Offices

Similar companies

Gameto

4 followers

Clint

18 followers

Synthekine

3 followers

Kyverna Therapeutics

7 followers

Tango Therapeutics

2 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

Merck

230 followers

Generate Biomedicines

3 followers

Day One Biopharmaceuticals

1 follower

Explore companies